PostureCheck: A Vision-based Compensatory-posture-detection Tool for Robot-assisted Upper-limb Th… (NCT04851886) | Clinical Trial Compass
RecruitingNot Applicable
PostureCheck: A Vision-based Compensatory-posture-detection Tool for Robot-assisted Upper-limb Therapy
United States42 participantsStarted 2024-04-26
Plain-language summary
The overall objective of this study is to assess whether robot-assisted upper-limb group rehabilitation can be effectively delivered by using a camera-based system equipped with machine learning algorithms to track the quality of the exercise performance and provide feedback accordingly. To address this question, we plan to carry out a randomized clinical trial to compare outcomes in subjects receiving robot-assisted upper-limb rehabilitation during individual (i.e., one-on-one) sessions and in subjects receiving robot-assisted upper-limb rehabilitation during group (i.e., up to three subjects) sessions.
Who can participate
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Have had a history of ischemic cerebrovascular accident (CVA) within middle cerebral artery (MCA) or anterior cerebral artery (ACA) territory
* CVA occurred between six months and six years ago
* Moderate to severe UE impairment, FMA-UE score between 15 and 45
* Mini-Mental State Examination (MMSE) score \>23 and being able to safely follow three-step commands
Exclusion Criteria:
* Advanced musculoskeletal pathology or recent fractures in the impaired UE
* Previous diagnosis of neurological diseases other than stroke
* Severe limitation of passive range of motion or spasticity (Modified Ashworth Scale for spasticity at \<3 for UE muscles)
* Hemorrhagic CVA or involvement of the posterior cerebral artery
* Aphasia sufficient to limit ability to express needs or discomfort verbally or non-verbally
* Impaired visual acuity (Severe visual impairments as assessed by the NIH Stroke Scale Visual Field subscale. (score \>0))
* Severe hemispatial neglect as assessed by the Line Bisection Test (score \>2)
* Severely impaired trunk control (\<4)
* Individuals who present with the following on the intended limb:
* Open wounds
* Fragile skin
* Under contact precautions due to an active infection
* Participation in another therapy focused on recovery of the impaired arm
* Subjects with cardiac pacemakers, electronic pumps or any other implanted medical devices, that are not US-certified
* Any Condition that would prevent safe use of the Burt system; such as proprio…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change from baseline Fugl-Meyer Assessment - Upper Extremity (FMA-UE) at 7-8 weeks
Timeframe: Data will be collected at baseline and at 7-8 weeks